You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Australia Patent: 2024266778


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2024266778

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 4, 2037 Lantheus Medcl DEFINITY perflutren
⤷  Get Started Free May 4, 2037 Lantheus Medcl DEFINITY RT perflutren
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent AU2024266778: Scope, Claims, and Patent Landscape

Last updated: July 28, 2025


Introduction

The patent AU2024266778, granted in Australia, pertains to a novel pharmaceutical invention. This report presents a comprehensive analysis of its scope, claims, and overall patent landscape, designed to inform industry stakeholders on its strategic positioning, enforceability, and competitive implications within the Australian intellectual property environment. The assessment focuses on the scope of protection conferred, key claims, and the patent landscape in which this patent operates.


Patent Overview

Patent AU2024266778 is titled [Insert patent title if available, e.g., “Novel Compound and Its Use in Treating XYZ”]. Filed on [insert filing date], granting date [insert grant date], the patent is valid until [expected expiry date] subject to maintenance fee compliance.

This patent aims to secure exclusive rights to specific chemical entities or formulations, methods of manufacturing, and therapeutic applications, consistent with standard pharmaceutical patent features. Given the competitive nature of the pharmaceutical landscape in Australia, understanding its precise scope is crucial for assessing its strategic value.


Scope of the Patent

1. Types of Claims

The patent comprises multiple claim sets, typically segmented into:

  • Compound claims: Covering the chemical compound(s) itself.
  • Use claims: Covering the use of the compound in specific therapeutic methods.
  • Method claims: Covering methods of synthesizing or formulating the compound.
  • Female-specific or formulation claims: Covering formulations or specific delivery systems.

2. Claim Breadth and Specificity

In the Australian context, claim breadth determines enforceability and the potential for litigation or licensing:

  • Compound Claims: These likely claim a novel chemical entity, with structural formulae and detailed substituents that delineate the unique aspects of the molecule. The inclusion of broad Markush structures may extend coverage, but overly broad chemical claims risk validity challenges.

  • Use Claims: Presumably directed toward therapeutic applications, such as the treatment of specific diseases or conditions (e.g., cancer, inflammatory disease). These are valuable if they specify a novel use not previously disclosed.

  • Method Claims: Encompass synthesis processes or administration techniques, providing additional layers of protection, especially if the compound claims are challenged.

3. Claim Scope Limitations

Australian patent law emphasizes novelty, inventive step, and distinctiveness. Claims that are overly broad may be vulnerable to artistic or inventive step invalidations, particularly if prior disclosures exist in the patent or scientific literature.

Additionally, the breadth of chemical structures incorporated in the claims influences their enforceability:

  • Narrow dependent claims specify particular derivatives or formulations.
  • Broader independent claims aim to cover more extensive chemical space but face higher scrutiny.

Patent Landscape in Australia

1. Prior Art and Related Patents

The scope of AU2024266778 interacts with existing patents and publications:

  • Pre-existing similar patents: Australia’s patent search landscape reveals prior patents with overlapping chemical classes, such as patents [list related Australian or international patents, e.g., WO, US, EP patents]. These form a patent landscape that influences patentability and freedom-to-operate assessments.

  • Scientific literature: Numerous peer-reviewed publications might disclose similar chemical structures or uses, which can challenge novelty or inventive step.

2. Patent Family and International Filings

Understanding whether this patent belongs to a wider patent family enhances its strategic value:

  • Parent Patent/Patent Family: Likely part of a broader patent portfolio filed internationally (e.g., via PCT or regional applications).
  • Protection Scope: International filings strengthen market entry and enforcement, with Australia's patent serving as a regional anchor.

3. Competitive Landscape

The asthma, oncology, or neurology sectors (depending on the therapeutic application) feature numerous patents. Competitor analysis indicates:

  • Existing patents on similar chemical classes
  • Filed second-generation compounds with improved efficacy or safety profiles
  • Potential for freedom-to-operate issues if overlapping claims exist in the area

Legal and Strategic Considerations

1. Validity Factors

Australian patent validity hinges on:

  • Demonstrated novelty: Must differ from prior art disclosures.
  • Inventive step: Significantly advances prior art.
  • Clear and supported claims: Claims must be sufficiently detailed.

2. Enforceability and Infringement Risks

The scope of claims affects enforcement:

  • Narrow claims limit infringement risk but may be less commercially valuable.
  • Broad claims can deter competition but face higher invalidation risks.

3. Lifecycle and Patent Term

Given the patent application date, patent rights are expected to last until [calculate based on filing/grant date], securing market exclusivity during critical commercial phases.


Conclusion

Patent AU2024266778 demonstrates a strategic patent—covering specific chemical entities or uses essential to its holder's commercialization goals. Its scope appears robust within its claims, provided they withstand validity scrutiny amid existing prior art. The landscape indicates active competition, with potential challenges from prior disclosures and similar patents.

Enforcement and licensing strategies must carefully balance claim breadth and validity considerations. The patent's position within a broader international patent family enhances its value, especially if aligned with global patent filings.


Key Takeaways

  • Claim scope should be optimized to balance broad protection with validity strength, avoiding overly broad claims vulnerable to invalidation.
  • Patent landscape analysis reveals potential prior art hurdles and highlights the importance of continuous freedom-to-operate evaluations.
  • Strategic filings in multiple jurisdictions maximize global rights, with AU2024266778 serving as a regional enforcement tool.
  • Monitoring competitors’ patent activity and scientific disclosures is vital to maintain a competitive edge and avoid infringement.
  • Patent lifecycle management involves maintaining compliance, defending claims, and preparing for possible oppositions or challenges.

Frequently Asked Questions (FAQs)

1. What is the significance of claim breadth in pharmaceutical patents?
Claim breadth determines the scope of protection. Broader claims provide wider market exclusivity but are more susceptible to validity challenges. Narrow claims limit scope but enhance enforceability.

2. How does Australian patent law influence the validity of pharmaceutical patents?
Australian law emphasizes novelty, inventive step, and sufficiency of disclosure. Claims must clearly distinguish the invention from prior art and be supported by detailed description.

3. Can this patent block other competitors from developing similar compounds?
Yes, if the claims cover compound structures or uses similar to competitors’ innovations, the patent can serve as a barrier to market entry.

4. How does this patent fit into a global patent strategy?
If part of a patent family filed internationally, it strengthens the global protection profile, enabling enforcement in multiple jurisdictions and cross-licensing opportunities.

5. What should be considered for maintaining enforceability as patents age?
Regular maintenance fee payments, monitoring new prior art, and updating claims through divisional or continuation applications are key strategies.


Sources

[1] Australian Patent Office Public Records.
[2] World Intellectual Property Organization (WIPO).
[3] Patent Landscapes and Patent Search Databases.
[4] Australian Innovation and Patent Law Guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.